Edition:
United Kingdom

Pernix Therapeutics Holdings Inc (PTX.OQ)

PTX.OQ on NASDAQ Stock Exchange Global Market

2.31USD
8:06pm GMT
Change (% chg)

$-0.12 (-4.94%)
Prev Close
$2.43
Open
$2.42
Day's High
$2.43
Day's Low
$2.31
Volume
22,122
Avg. Vol
24,865
52-wk High
$7.15
52-wk Low
$1.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 34.32 -2.158
Mar '17 29.74 -2.941
FY 2016 Dec '16 30.17 -8.908
Sep '16 41.47 -2.990
Jun '16 36.75 -4.669
Mar '16 32.47 -4.243
FY 2015 Dec '15 46.37 -13.349
Sep '15 48.62 -1.762
Jun '15 46.98 -6.152
Mar '15 33.89 -6.157
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta 1.69 0.90 0.88
Price to Sales (TTM) 0.26 3.93 5.40
Price to Book (MRQ) -- 4.81 5.38
Price to Tangible Book (MRQ) -- 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 21.30 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -6.61 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago -17.36 4.66 5.38
Sales - 5 Yr. Growth Rate 18.37 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 53.78 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 29.25 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate 41.15 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.67 2.11 2.18
Current Ratio (MRQ) 0.75 2.88 2.98
LT Debt to Equity (MRQ) -- 9.47 11.56
Total Debt to Equity (MRQ) -- 13.43 15.81
Interest Coverage (TTM) -9.29 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 70.21 55.14 54.83
Gross Margin - 5 Yr. Avg. 64.57 52.29 52.40
EBITD Margin (TTM) 4.02 -- --
EBITD - 5 Yr. Avg -0.57 18.46 15.24
Operating Margin (TTM) -93.55 14.50 7.76
Operating Margin - 5 Yr. Avg. -56.18 14.42 10.75
Pre-Tax Margin (TTM) -120.18 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -69.72 14.74 11.17
Net Profit Margin (TTM) -120.56 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -65.04 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 733,508 953,213,828 864,673,321
Net Income/Employee (TTM) -884,286 112,151,383 101,717,508
Receivable Turnover (TTM) 2.90 5.60 5.76
Inventory Turnover (TTM) 4.45 2.58 3.34
Asset Turnover (TTM) 0.42 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.40 11.42 11.00
Return on Assets - 5 Yr. Avg. -23.23 13.00 12.43
Return on Investment (TTM) -74.47 14.86 14.46
Return on Investment - 5 Yr. Avg. -31.36 17.00 16.28
Return on Equity (TTM) -- 16.28 16.05
Return on Equity - 5 Yr. Avg. -138.91 18.03 17.51
  1 Year 3 Year 5 Year
Sales % -19.90 18.40 18.37
EPS (TTM) % 22.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pernix Therapeutics Holdings Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 20.96%
# of Holders: 42
Total Shares Held: 2,416,912
3 Mo. Net Change: 189,469
# New Positions: 8
# Closed Positions: 6
# Increased Positions: 15
# Reduced Positions: 11
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.